BiotechTube
Home/GlyProVac/Ann Zahle Andersen
AZ

Ann Zahle Andersen

Co-founder

GlyProVac

Therapeutic Areas

Infectious DiseaseAntimicrobial Resistance

GlyProVac Pipeline

DrugIndicationPhase
GPV02Pan-E. coli infections (UTIs, neonatal sepsis, diarrhoea)Pre-clinical

Leadership Team at GlyProVac

AB
Anders Boysen
Founder
JM
Jakob Møller-Jensen
Co-inventor (BEMAP)
MR
Martin Røssel Larsen
Co-inventor (BEMAP)
GP
Giuseppe Palmisano
Co-inventor (BEMAP)
View full GlyProVac profile